Tabled by: Greg Mulholland (Liberal Democrat - Leeds North West)
That this House is aware that the pause in NHS England's decision-making process on prioritisation and specialised commissioning has created a block to accessing effective medicines for rare diseases where there are commissioning policies under development or assessment; notes that for conditions such as Duchenne muscular dystrophy, tuberous sclerosis and …
63 signatures
(Most recent: 24 Mar 2015) Signatures by party:
Labour: 21 Conservative: 5 Democratic Unionist Party: 4 Independent: 3 Plaid Cymru: 1 Green Party: 1